Islanders GM Lou Lamoriello's facial hair policy found its most recent victim this week in Kyle Palmieri. It's time to put hockey's worst unwritten rules to bed.
Islanders GM Lou Lamoriello's facial hair policy found its most recent victim this week in Kyle Palmieri. It's time to put hockey's worst unwritten rules to bed.
Fuel supply constraints along the U.S. East Coast should ease in coming days, U.S. Energy Secretary Jennifer Granholm said on Thursday, a day after Colonial Pipeline late Wednesday said it had restarted its key pipeline. In separate television interviews, Granholm told MSNBC and CNN the current fuel shortages are temporary and that most areas should be back to normal in a couple of days. The shutdown of the major fuel artery last weekend following a ransomware attack triggered shortages and sent people in some states along the southeastern United States scrambling to fill their cars, creating long lines and higher prices.
Egypt has played a mediating role in the past between the sides.
Don McGahn, who served as White House counsel under former U.S. President Donald Trump, has agreed to be interviewed by the House Judiciary panel after a years-long legal battle, according to the Democratic chairman of the committee. The deal follows a two-year fight for the lawyer's testimony as House Democrats sought to enforce a subpoena for McGahn's testimony as part of its investigation into Trump's efforts to impede former Special Counsel Robert Mueller's investigation that documented Russian interference in the 2016 U.S. election. McGahn, who left his post in late 2018 halfway through Trump's four-year term, had declined to testify in May 2019.
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Plant-Based-Meat Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. Plant-Based-Meat Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global plant-based meat Market. Major players in the plant-based-meat market are Amy's Kitchen, The Vegetarian Butcher, Maple Leaf Foods, Beyond Meat, Impossible Foods, Greenleaf Foods, Hungry Planet, Next Level and Abbots Butcher.The global plant-based-meat market is expected to grow from $11.86 billion in 2020 to $13.28 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $20.78 billion in 2025 at a CAGR of 12%.The high prices of plant-based meat products in comparison with regular meat products is a major restraint for the growth of the plant-based meat market. The major players dealing in plant-based meat products are beyond burger and impossible burger. At Whole Foods, an America-based multinational supermarket chain, the retail price of beyond burger is USD 12 a pound, whereas regular ground beef burger costs for less than half i.e. USD 5 a pound. Thus, the differences in the prices of plant-based meat products and regular meat products are predicted to hinder the growth of the market over the upcoming years.Increasing consumer awareness associated with the benefits of vegetarian diets is projected to contribute to the growth of the plant-based meat market. The vegetarian diets offer various benefits such as low insulin levels, decreased rate of heart diseases, and improved kidney functions. According to Vegconomist, the vegan business magazine article published in July 2019, plant-based meat contains lower levels of cholesterol, saturated fat, and calories in comparison with animal-based meat. Moreover, rising consumer awareness on animal rights through global welfare organizations such as animal aid unlimited (AAU) and people for the ethical treatment of animals (PETA) is to boost the demand for plant-based meat products, which in turn, is predicted to uptake the revenues of plant-based meat market over the forecast period.The plant-based meat market covered in this report is segmented by product type into burger patties; sausages; strips; nuggets; meatballs; others. It is also segmented by source into soy; wheat; pea; others.The increasing launch of new innovative products that are made from plant-based meat is a major trend in the plant-based meat market. For instance, in June 2019, the world's largest meat producer announced the sales of preprotein made nuggets at grocery stores as a part of a new brand, Raised & Rooted that is engaged in selling blended and plant-based meat products. Moreover, in June 2019, a leader in plant-based meat announced the launch of its new product, Beyond Beef. Beyond Beef is new plant-based ground meat prepared without GMOs, gluten or soy designed to deliver meaty texture, juiciness, and the same versatility of traditional beef. In March 2018, Kerry Group, an Ireland-based public food company, announced a major move into the meat substitutes market with the acquisition of Ojah, an innovative producer of textured meat alternatives based in the Netherlands for an approximate amount of USD 24 billion. Ojah is engaged in making a wide range of meat alternative products under Plenti and Beeter Brands. The Ojah products comprise seasoned & natural chunks and strips and vegan nuggets. The products are gluten-free and are made from pea or soy protein.Key Topics Covered: 1. Executive Summary 2. Plant-Based Meat Market Characteristics 3. Plant-Based Meat Market Trends and Strategies 4. Impact of COVID-19 on Plant-Based Meat 5. Plant-Based Meat Market Size and Growth 5.1. Global Plant-Based Meat Historic Market, 2015-2020, $ Billion 5.1.1. Drivers of the Market 5.1.2. Restraints on The Market 5.2. Global Plant-Based Meat Forecast Market, 2020-2025F, 2030F, $ Billion 5.2.1. Drivers of the Market 5.2.2. Restraints on the Market 6. Plant-Based Meat Market Segmentation 6.1. Global Plant-Based Meat Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Burger PattiesSausagesStripsNuggetsMeatballsOthers 6.2. Global Plant-Based Meat Market, Segmentation By Source, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion SoyWheatPeaOthers 6.3. Global Plant-Based Meat Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Grocery StoresFood & Drinks Specialty StoresConvenience StoresRestaurantsOnline Stores 7. Plant-Based Meat Market Regional and Country Analysis 7.1. Global Plant-Based Meat Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion 7.2. Global Plant-Based Meat Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Companies Mentioned Amy's KitchenThe Vegetarian ButcherMaple Leaf FoodsBeyond MeatImpossible FoodsGreenleaf FoodsHungry PlanetNext LevelAbbots ButcherAtlantic Natural FoodsDon Lee FarmsDr. Praeger'sGardeinGood Catch FishKraft Heinz FoodserviceMonks MeatsMorningStar FarmsNo Evil FoodsOcean Hugger FoodsQuorn FoodsSophie's KitchenSweet EarthTofurkyVBitesYves Veggie Cuisine For more information about this report visit https://www.researchandmarkets.com/r/bys41p CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Police are at the scene in the southside of Glasgow.
Given their healthy growth prospects, these four Canadian stocks could be excellent additions to your TFSA. The post TFSA Investors: Here Are 4 High-Growth Stocks That You Can Buy Right Now appeared first on The Motley Fool Canada.
Graceland’s Performing Arts Camp announces Broadway touring star Patrick Dunn will be a guest mentor for the 5 day arts experience for kids and teens.
Reports continued progress towards start of Phase 3 trialsHERZLIYA, Israel, May 13, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2021. The Company also announces it has finalized the protocol for its Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery for submission to the regulatory authorities. Ilan Hadar, Chief Executive Officer of PainReform, commented, "We continue to make progress towards commencing our Phase 3 clinical trials of PRF-110. Towards this end, we have been manufacturing clinical trial batches of PRF-110 in preparation for the Phase 3 clinical trials and are working to address delays due to our CMC partner. We currently expect to commence our bunionectomy Phase 3 clinical trial toward the end of the third quarter of this year. We also hired a new head of clinical operations, which follows the appointment of Lotus Clinical Research as our clinical research organization to oversee the two clinical trials in patients undergoing bunionectomy and hernia repair operations." Mr. Hadar continued, "Assuming our Phase 3 clinical trials are successful, we believe PRF-110 will address an important unmet need in the market, especially as an alternative to systemic opioids, which have contributed to the opioid epidemic. Moreover, we have maintained a strong balance sheet, with cash and cash equivalents of $19.4 million as of March 31, 2021, which we believe should be more than sufficient to support our ongoing activities beyond completion of our first Phase 3 trial and reporting top-line data." "Marjorie D. Tamblyn, our new head of clinical operations in the U.S., brings over 20 years of experience in clinical operations leadership in the pharmaceutical/biotech and Clinical Research Organization industry and will be an important addition to the team as we advance our clinical trials and begin preparations for commercial activities. Her skill sets and leadership skills should be invaluable as we work towards our goal of establishing PRF-110 as the standard of care in the post-operative non-opiate pain treatment market. We remain highly encouraged by our prior data, which demonstrated a strong safety profile, suggesting a substantial advantage to using PRF-110 over the local anesthetic, ropivacaine." Financial Results for the First Quarter Ended March 31, 2021 Research and development expenses were $1,029,000 for the three months ended March 31, 2021 compared to $24,000 for the three months ended March 31, 2020, an increase of $1,005,000. The increase was primarily due to an increase in CMC activities and preparation for the initiation of clinical trials. General and administrative expenses were $1,010,000 for the three months ended March 31, 2021 compared to $108,000 for the three months ended March 31, 2020, an increase of $902,000 or 835%. The increase was primarily due to costs related with us becoming a publicly traded company commencing September 2020, an increase in headcount related costs and an increase in certain professional services costs. Financial expense, net was $2,000 for the three months ended March 31, 2021 compared to financial expenses, net of $1,164,000 for the three months ended March 31, 2020, a decrease of $1,162,000. The decrease was primarily due to a decrease in change in fair value of derivative warrant liability, and interest expense and amortization of discount on convertible notes. As a result of the foregoing, the Company incurred a net loss of $2,041,000 for the three months ended March 31, 2021 compared to a net loss of $1,296,000 for the three months ended March 31, 2020, an increase of $745,000 or 57%. As of March 31, 2021, the Company had cash and cash equivalents of $19,424,000. About PainReform PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. PRF-110, the Company's lead product, is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The Company's proprietary extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. Notice Regarding Forward-Looking StatementsThis press release contains forward looking statements about our expectations, beliefs and intentions. Forward-looking statements can be identified by the use of forward-looking words such as "believe", "expect", "intend", "plan", "may", "should", "could", "might", "seek", "target", "will", "project", "forecast", "continue" or "anticipate" or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our initial product candidate, PRF-110; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110 and future product candidates; the impact of the COVID-19 pandemic on our operations; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; commercial success and market acceptance of our product candidates; our ability to establish sales and marketing capabilities or enter into agreements with third parties and our reliance on third party distributors and resellers; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; and statements as to the impact of the political and security situation in Israel on our business. More detailed information about the risks and uncertainties affecting us is contained under the heading "Risk Factors" included in the Company's most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future. Contact: Crescendo Communications, LLCTel: 212-671-1021Email: email@example.com Ilan HadarChief Executive OfficerPainReform Ltd.Tel: +972-54-5331725Email: firstname.lastname@example.org
Englewood Cliffs, NJ, May 13, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that its investigator led study using Psilocybin to treat Parkinson’s disease has been submitted for ethics board review in the Netherlands. Eric Weisblum, CEO of Silo Pharma stated “We are pleased to have reached this milestone and look forward to sharing further information on this study with the scientific community and our shareholders.” About Silo Pharma Silo Pharma. Inc. is a development stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry. For more information, visit www.silopharma.com Safe Harbor and Forward-Looking Statements This news release contains "forward-looking statements" within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential” and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (“Silo” or “the Company”) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether as a result of new information, future events or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law. Investor Relations Contact:Hayden IRBrett Maas646-536-7331Email: email@example.com
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / H2O Innovation, Inc. (OTCQX:HEOFF) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Fuel Tech, Inc. (NASDAQ:FTEK) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / The Green Organic Dutchman Holdings Ltd. (OTCQX:TGODF) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Northland Power, Inc. (OTC PINK:NPIFF) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Suzano SA (NYSE:SUZ) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Pampa Energia SA (NYSE:PAM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Innovative Solutions & Support, Inc. (NASDAQ:ISSC) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Wesdome Gold Mines Ltd. (OTC PINK:WDOFF) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Celsius Holdings, Inc. (NASDAQ:CELH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 10:00 AM Eastern Time.
The fitness industry has seen an immense shift over the past year as the pandemic affected routines and emphasized the need to invest in our wellbeing. As a result of these changes, many turned to fitness as an outlet. In fact, according to a recent survey by Gympass, 42.8% of people said that physical activity was the most impactful thing to take care of their mental wellbeing during the pandemic. As the transition back to ‘normal’ continues a majority of people (64.6%) are excited to go back to gyms and studios in person, changing what the fitness experience will look like moving forward.
ABS module design segment has the fastest growth in the alpha methylstyrene market in 2019 and the market is forecasted to grow with the significant rate of above 4% CAGR over the forecast period.Dallas, Texas, May 13, 2021 (GLOBE NEWSWIRE) -- The advancement in technology and demand for consumer goods from emerging economies has been providing opportunities for market growth. ABS resins benefit from the addition of alpha-methylstyrene because it increases thermal resilience and impact tolerance. The ABS segment of the alpha-methylstyrene industry is growing due to increased demand for ABS resins from various end-use industries such as automotive and electronic appliances. Purity of over 99.5 percent means that the chemical mixture contains pure alpha-methylstyrene in excess of 99.5 percent. The higher the purity level of alpha-methylstyrene, the greater number of applications of its products in the market. Request to Sample PDF Brochure: https://www.adroitmarketresearch.com/contacts/request-sample/2075 The report also outlines the various characteristics of the global alpha-methylstyrene industry by assessing the market from value chain analysis. Moreover, the alpha-methylstyrene market report comprises various qualitative parts of the alpha-methylstyrene industry in market restraints, essential industry drivers, and opportunities. Furthermore, the report provides a complete assessment of the market through company profiling and the competitiveness of the local as well as global vendors. The alpha-methylstyrene market has huge competition amongst the already well-known and new market players. Also, the alpha-methylstyrene industry players are pursuing potential markets to seize a competitive lead among the other industry players by forming mergers & acquisitions, agreements, acquiring other companies & new startups, establishing collaboration & partnerships, and growing their business existence. Alpha-methylstyrene is used as a heat stabilizer for ABS, as a solvent in the plastics industry, and as a dye and paint adhesive agent in adhesives & coatings, waxes, and tackifiers with purity above 99.5 percent. It's also used in the beauty and food industry. As an antioxidant, a refined polyester, and an alkyd resin, alpha-methylstyrene is used. 98.5 percent purity is the global industrial benchmark for alpha-methylstyrene. The majority of alpha-methylstyrene factories around the world produce alpha-methylstyrene with a purity level of 98.5 percent or higher. Browse this report in detail along with the table of contents, please click the link below: https://www.adroitmarketresearch.com/industry-reports/alpha-methylstyrene-market China, India, Japan, and South Korea are major contributors to the region's rising market for alpha-methylstyrene. Increased demand for consumer durables and vehicles in Asia Pacific has been fueled by innovations in electronic appliance manufacturing techniques, demographic growth, and rising middle-class wages, all of which have contributed to the region's alpha-methylstyrene industry growth. The major players of the global alpha-methylstyrene market are INEOS Group Holding S.A. (Switzerland), AdvanSix (US), Rosneft (Russia), Altivia Corp. (US), SI Group Inc. (US), DOMO Chemicals (Belgium), Kumho P&B Chemicals (South Korea), Taiwan Prosperity Chemical Corp. (Taiwan), Yangzhou Lida Chemicals (China), Mitsubishi Chemical Corporation (Japan), Solvay SA (Belgium), and Mitsui Chemicals, Inc. (Japan). The major players in the market comes up with some of the developments to enhance the market growth in the global industry. Have Any Query? Ask Our Experts: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/2075 Table of Content: Chapter 1 Introduction Chapter 2 Research Methodology Chapter 3 Executive Summary Chapter 4 Market Outlook Chapter 5 Alpha-Methylstyrene Market by Purity, 2018-2028 (USD Million) (Kilo Tons) Chapter 6 Alpha-Methylstyrene Market by Application, 2018-2028 (USD Million) (Kilo Tons) Chapter 7 Alpha-Methylstyrene Market by Region, 2018-2028 (USD Million) (Kilo Tons) Chapter 8 Competitive Landscape Chapter 9 Company Profiles Have a Look at Related Reports: Engineered Fluids (Fluorinated Fluids) Market by Type (Lubricants, Solvents, Heat Transfer Fluids), End-Use Industry (Electronics & Semiconductor, Automotive, Chemical Processing, Oil & Gas, Power Generation, Aerospace), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Forecast, 2018 to 2028 Global Carbon Offset/ Carbon Credit Trading Service Market by Form (Solid, Liquid), by Application (Industrial. Reagent, Pharma) and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, South America), Global Forecast, 2018 to 2028 Global Neonicotinoid Pesticides Market by Type (Alkoxy Ethyl-based, Ethyl Ester-based, Methyl Ester-based, Other Product Types), by Application (Transportation, Footwear and Leather, Furniture, Consumer Goods, Healthcare, Electronics, Other End-user Industries) and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, South America), Global Forecast, 2018 to 2028 Contact Us:Ryan JohnsonAccount Manager - Global3131 McKinney Ave Ste 600Dallas, TX 75204Email ID: firstname.lastname@example.orgPhone No.: +1 972-362 -8199Connect with us: Facebook | Twitter | LinkedIn